EMC Instytut Medyczny SA (WSE:EMC)
Poland
· Delayed Price · Currency is PLN 10.90
+0.10 (0.93%)
Apr 3, 2025, 9:01 AM CET
EMC Instytut Medyczny Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 809.41 | 682.21 | 575.06 | 514.77 | 441.36 | Upgrade
|
| Revenue Growth (YoY) | 18.65% | 18.63% | 11.71% | 16.63% | 7.54% | Upgrade
|
| Cost of Revenue | 403.98 | 350.65 | 459.96 | 407.58 | 245.74 | Upgrade
|
| Gross Profit | 405.43 | 331.56 | 115.09 | 107.19 | 195.62 | Upgrade
|
| Selling, General & Admin | 344.67 | 282.13 | 4.38 | 2.56 | 176.82 | Upgrade
|
| Other Operating Expenses | 3.33 | -3.54 | 105.52 | 96.24 | -4.28 | Upgrade
|
| Operating Expenses | 380.16 | 310.81 | 110.05 | 98.86 | 193.38 | Upgrade
|
| Operating Income | 25.27 | 20.74 | 5.05 | 8.33 | 2.24 | Upgrade
|
| Interest Expense | -6.04 | -5.9 | -4.24 | -2.91 | -5.51 | Upgrade
|
| Interest & Investment Income | - | - | 0.02 | 0.58 | 0.28 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -1.25 | -0.21 | -2.79 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | 5.88 | -0.13 | -0.17 | -0.35 | Upgrade
|
| EBT Excluding Unusual Items | 19.22 | 20.72 | -0.56 | 5.61 | -6.12 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.28 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.77 | 0.06 | 1.28 | Upgrade
|
| Legal Settlements | - | - | -0.01 | -0.07 | -0.03 | Upgrade
|
| Other Unusual Items | - | - | -0.44 | 0.83 | - | Upgrade
|
| Pretax Income | 19.22 | 20.72 | -0.24 | 6.44 | -5.16 | Upgrade
|
| Income Tax Expense | 4.63 | 3.38 | 1.29 | 2.8 | 2.06 | Upgrade
|
| Earnings From Continuing Operations | 14.59 | 17.34 | -1.53 | 3.64 | -7.22 | Upgrade
|
| Minority Interest in Earnings | -2.26 | -1.91 | -0.13 | -1.01 | -0.48 | Upgrade
|
| Net Income | 12.33 | 15.43 | -1.66 | 2.63 | -7.7 | Upgrade
|
| Net Income to Common | 12.33 | 15.43 | -1.66 | 2.63 | -7.7 | Upgrade
|
| Net Income Growth | -20.09% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 42 | 42 | 41 | 23 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 42 | 42 | 41 | 23 | 22 | Upgrade
|
| Shares Change (YoY) | 2.29% | 0.19% | 82.45% | 2.38% | 64.60% | Upgrade
|
| EPS (Basic) | 0.29 | 0.37 | -0.04 | 0.12 | -0.35 | Upgrade
|
| EPS (Diluted) | 0.29 | 0.37 | -0.04 | 0.12 | -0.35 | Upgrade
|
| EPS Growth | -21.88% | - | - | - | - | Upgrade
|
| Free Cash Flow | -8.39 | 10.76 | 7.24 | -8.79 | -5.45 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | 0.26 | 0.17 | -0.39 | -0.25 | Upgrade
|
| Gross Margin | 50.09% | 48.60% | 20.01% | 20.82% | 44.32% | Upgrade
|
| Operating Margin | 3.12% | 3.04% | 0.88% | 1.62% | 0.51% | Upgrade
|
| Profit Margin | 1.52% | 2.26% | -0.29% | 0.51% | -1.75% | Upgrade
|
| Free Cash Flow Margin | -1.04% | 1.58% | 1.26% | -1.71% | -1.23% | Upgrade
|
| EBITDA | 57.43 | 52.96 | 24.47 | 26.15 | 15.46 | Upgrade
|
| EBITDA Margin | 7.09% | 7.76% | 4.25% | 5.08% | 3.50% | Upgrade
|
| D&A For EBITDA | 32.15 | 32.22 | 19.42 | 17.82 | 13.22 | Upgrade
|
| EBIT | 25.27 | 20.74 | 5.05 | 8.33 | 2.24 | Upgrade
|
| EBIT Margin | 3.12% | 3.04% | 0.88% | 1.62% | 0.51% | Upgrade
|
| Effective Tax Rate | 24.11% | 16.33% | - | 43.43% | - | Upgrade
|
| Revenue as Reported | 809.41 | 682.21 | - | - | 441.36 | Upgrade
|
Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.